may 7,2018 motley fool

From motley fool research Not sure if there is a proper write up somewhere Will try and find the references research also https://www.**promotion blocked**.au/2018/05/07/is-medlab-clinical-ltd-the-best-small-cap-healthcare-buy-on-the-asx/ Stocks in the healthcare sector are getting a lot of airplay at the moment, with the likes of Ramsay Health Care Limited Fully Paid Ord. Shrs (ASX: RHC) experiencing sharp falls in its share price off the back of rising health premiums out of NIB Holdings Limited (ASX: NHF) and Medibank Private Ltd (ASX: MPL). But at the small cap end of the scale brokers are circling biological research company Medlab Clinical Ltd (ASX: MDC) as a potential buy in, albeit, it is only one to consider for investors who don’t mind speculative stocks in their portfolio. Analysts at Asia Pacific Prudential Securities (APP) have placed a buy rating on Medlab with a $1.20 target price – Medlab shares were down 0.7% to 66c per share at the time of writing. It is forecast by APP that Medlab is about to enter a period of strong earnings growth off the back of its medicinal marijuana products with NanaBis. Medlab completed a $24 million capital raising in January this year, but will likely need to raise more capital soon for the rollout of its new products. It’s a speculative pick for sure, and investors would have to do their own research before they make the call on Medlab, but the company has been granted licenses to supply Schedule 8 drugs, which will include NanaBis under the governments Special Access Scheme (SAS). From speculative shares to the disruptors...find out which 3 Revolutionary Aussie Companies to Back for 2018 We're living in one of the most exciting times in investing history. Innovation and a booming culture of entrepreneurship are constantly creating new companies with the potential to make forward-thinking investors very rich. Now more than ever, one small, smart investment could make a huge difference to your wealth. That's why at The Motley Fool we've been scrutinizing the ASX to uncover the kinds of companies that we believe could turn into the next Cochlear or REA Group. We've found three exciting companies that we believe re poised to perform in the new year. Click here to uncover these ideas! Motley Fool contributor Carin Pickworth has no position in any of the stocks mentioned. The Motley Fool Australia has recommended NIB Holdings Limited and Ramsay Health Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.